Alkermes
Alkermes is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience.
2428 employees · est. 1987 · Dublin, Ireland
Neurocrine Biosciences
You Deserve Brave Science
2403 employees · est. 1992 · San Diego, United States
Alkermes is the older company (1987 vs 1992).
Side-by-Side Comparison
| Metric | Alkermes | Neurocrine Biosciences |
|---|---|---|
| Founded | ||
| Founded | 1987 older | 1992 |
| Headquarters | ||
| Headquarters | Dublin, Ireland | San Diego, United States |
| Employees | ||
| Employees | 2428 | 2403 |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biotechnology |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | IPO |
| Total Funding | ||
| Total Funding | $250.00M | $1.09B |
| Funding Rounds | ||
| Funding Rounds | 2 | 5 |
| Services | ||
| Services | Not tracked yet | Drug Development, Clinical Trials, Scientific Research, Pipeline Management, Research and Development |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with Rare or Untreatable Conditions, Healthcare Professionals, Medical Researchers, Pharmaceutical Investors, Healthcare Institutions |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Neuroscience, Medicines, Psychiatric Disorders, Neurological Disorders, Alcohol Dependence, Opioid Dependence, Schizophrenia, Bipolar I Disorder, Clinical Research, Preclinical Research, Patient-Centered, Global Operations, R&D Center, Manufacturing Facilities | Biopharmaceuticals, Neurological Disorders, Psychiatric Disorders, Endocrine Disorders, Immunological Disorders, Tardive Dyskinesia, Huntington's Disease, Congenital Adrenal Hyperplasia, Endometriosis, Uterine Fibroids, FDA-approved Treatments, Clinical Development, Neuroscience, Brain-Body Systems, Movement Disorders |
| Website | ||
| Website | alkermes.com | neurocrine.com |
About Alkermes
Alkermes is a global biopharmaceutical company, founded in 1987, focused on developing innovative medicines for neuroscience. The company's portfolio includes commercial products for alcohol dependence, opioid dependence, schizophrenia, and bipolar I disorder, as well as a pipeline of candidates for...
About Neurocrine Biosciences
Neurocrine Biosciences, founded in 1992, is a prominent biopharmaceutical company committed to discovering and developing treatments for neurological, psychiatric, endocrine, and immunological disorders. Their mission, encapsulated by the slogan, "You Deserve Brave Science," drives their focus on ad...
We will tell you when either one moves
BounceWatch watches Alkermes and Neurocrine Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Alkermes and Neurocrine Biosciences — by email.
Frequently Asked Questions
Compare Alkermes with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Alkermes on 9 Jun 2026, and Neurocrine Biosciences on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
